USA-based leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, CareDx acquired MediGo. The latter is a company specialing in healthcare supply chain technology and software solutions. The company announced the acquisition on July 25, 2023. However, the company did not disclose the amount of the transaction.
Purpose of acquisition for CareDx
With the latest acquisition of MediGo, CareDx seeks to expand its digital health portfolio. It aims to better serve the organ procurement organization (OPO) market.
Meanwhile, the company intends to strengthen its pre-transplant offerings. The solutions aims to shorten transplant wait times and increasing access to donated organs.
What the CareDx official has to add
Reg Seeto, CEO and President of CareDx said, “MediGO shares our patient-centric mission to improve the transplant journey and brings a wealth of expertise to CareDx. By leveraging our combined strengths, we will drive operational efficiencies, accelerate innovation, and deliver even greater value to the transplant ecosystem by addressing the serious organ transplant shortage. The MediGO acquisition is in line with our mission, long-term growth strategy, and we’re excited to invest in this best-in-class offering that is well-proven and rapidly gaining adoption.”
What the MediGo official has to comment
Scott Plank, Executive Chairman and Founder of MediGO, further added, “We are thrilled to join forces with CareDx. CareDx and MediGO hold shared values and a mission to deliver transformational solutions that improve the transplant patient journey. Combining MediGO’s network, real-time data, and predictive analytics with CareDx’s digital health platform capabilities, we are better poised to deliver next-generation data-driven patient solutions. With MediGO’s people and technology solutions and CareDx, we expect to make a greater impact through this collaboration. We look forward to expanding our current offerings to OPOs, couriers, and hospitals and scaling the organ transplant system to deliver lifesaving organs and better outcomes for all who need them.”
In addition, Dr. Joseph Scalea, Co-founder and Chief Medical Officer of MediGO and Professor of Surgery at the Medical University of South Carolina, said, “We’re beyond excited that MediGO is joining CareDx. This synergistic partnership combines research-driven innovation and the best of clinical care. It’s an important step that will drive quality and critical access to transplantation for future generations of patients in need.”
About CareDx
Jay Wohlgemuth and Reginald Seeto launched the company in 1998. The company is a pioneer in precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers
For more extensive analysis and Market Intelligence reports, feel free to approach us.
We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know
if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover
–what information you are looking for in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Next Article
